216 related articles for article (PubMed ID: 38113335)
61. TLR2, TLR3 and TLR5 regulation of pro-inflammatory and pro-labour mediators in human primary myometrial cells.
Lim R; Barker G; Lappas M
J Reprod Immunol; 2017 Aug; 122():28-36. PubMed ID: 28844021
[TBL] [Abstract][Full Text] [Related]
62. Viperin interacts with the kinase IRAK1 and the E3 ubiquitin ligase TRAF6, coupling innate immune signaling to antiviral ribonucleotide synthesis.
Dumbrepatil AB; Ghosh S; Zegalia KA; Malec PA; Hoff JD; Kennedy RT; Marsh ENG
J Biol Chem; 2019 Apr; 294(17):6888-6898. PubMed ID: 30872404
[TBL] [Abstract][Full Text] [Related]
63. IRAK-M mediates Toll-like receptor/IL-1R-induced NFκB activation and cytokine production.
Zhou H; Yu M; Fukuda K; Im J; Yao P; Cui W; Bulek K; Zepp J; Wan Y; Kim TW; Yin W; Ma V; Thomas J; Gu J; Wang JA; DiCorleto PE; Fox PL; Qin J; Li X
EMBO J; 2013 Feb; 32(4):583-96. PubMed ID: 23376919
[TBL] [Abstract][Full Text] [Related]
64. Molecular characterization, expression and functional analysis of IRAK1 and IRAK4 in Nile tilapia (Oreochromis niloticus).
Han X; Gao F; Lu M; Liu Z; Wang M; Ke X; Yi M; Cao J
Fish Shellfish Immunol; 2020 Feb; 97():135-145. PubMed ID: 31846774
[TBL] [Abstract][Full Text] [Related]
65. Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
Sun J; Wiklund F; Hsu FC; Bälter K; Zheng SL; Johansson JE; Chang B; Liu W; Li T; Turner AR; Li L; Li G; Adami HO; Isaacs WB; Xu J; Grönberg H
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):480-5. PubMed ID: 16537705
[TBL] [Abstract][Full Text] [Related]
66. Cloning and functional characterization of IRAK1 from rainbow trout (Oncorhynchus mykiss).
Yang YC; Chen SN; Gan Z; Huang L; Nie P
Dev Comp Immunol; 2021 Jan; 114():103780. PubMed ID: 32745481
[TBL] [Abstract][Full Text] [Related]
67. IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation.
Sandig H; Jobbings CE; Roldan NG; Whittingham-Dowd JK; Orinska Z; Takeuchi O; Akira S; Bulfone-Paus S
Eur J Immunol; 2013 Apr; 43(4):979-88. PubMed ID: 23404570
[TBL] [Abstract][Full Text] [Related]
68. IRAK1 and IRAK4 signaling proteins are dispensable in the response of human neutrophils to Mycobacterium tuberculosis infection.
Kielbik M; Szulc-Kielbik I; Klink M
FEMS Microbiol Lett; 2019 Sep; 366(18):. PubMed ID: 31702785
[TBL] [Abstract][Full Text] [Related]
69. IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases.
Lavazais S; Jargosch M; Dupont S; Labéguère F; Menet C; Jagerschmidt C; Ohm F; Kupcsik L; Parent I; Cottereaux C; Marsais F; Oste L; Van de Water A; Christophe T; De Vos S; Fallon P; Lauffer F; Clément-Lacroix P; Eyerich K; Brys R
Sci Transl Med; 2023 Feb; 15(683):eabj3289. PubMed ID: 36791209
[TBL] [Abstract][Full Text] [Related]
70. IL-1R-associated kinase-1 mediates protein kinase Cδ-induced IL-1β production in monocytes.
Tiwari RL; Singh V; Singh A; Barthwal MK
J Immunol; 2011 Sep; 187(5):2632-45. PubMed ID: 21804018
[TBL] [Abstract][Full Text] [Related]
71. IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6.
Muroi M; Tanamoto K
Biochim Biophys Acta; 2012 Feb; 1823(2):255-63. PubMed ID: 22033459
[TBL] [Abstract][Full Text] [Related]
72. Targeting the Innate Immune Kinase IRAK1 in Radioresistant Cancer: Double-Edged Sword or One-Two Punch?
Liu PH; Sidi S
Front Oncol; 2019; 9():1174. PubMed ID: 31799178
[TBL] [Abstract][Full Text] [Related]
73. Molecular characterization and expressional modulation of IRAK1 as downstream signaling adaptor molecule of TLR-signaling pathways in Labeo rohita following PAMPs stimulation and bacterial infections.
Sadangi S; Mohanty A; Paichha M; Gouda S; Saha A; Das S; Samanta M
Fish Shellfish Immunol; 2020 Jan; 96():161-176. PubMed ID: 31786344
[TBL] [Abstract][Full Text] [Related]
74. The Emerging Roles of Pellino Family in Pattern Recognition Receptor Signaling.
Zhang E; Li X
Front Immunol; 2022; 13():728794. PubMed ID: 35197966
[TBL] [Abstract][Full Text] [Related]
75. Two phases of inflammatory mediator production defined by the study of IRAK2 and IRAK1 knock-in mice.
Pauls E; Nanda SK; Smith H; Toth R; Arthur JSC; Cohen P
J Immunol; 2013 Sep; 191(5):2717-30. PubMed ID: 23918981
[TBL] [Abstract][Full Text] [Related]
76. IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.
Cushing L; Winkler A; Jelinsky SA; Lee K; Korver W; Hawtin R; Rao VR; Fleming M; Lin LL
J Biol Chem; 2017 Nov; 292(45):18689-18698. PubMed ID: 28924041
[TBL] [Abstract][Full Text] [Related]
77. The IL-1R/TLR signaling pathway is essential for efficient CD8
Ma Z; Liu J; Wu W; Zhang E; Zhang X; Li Q; Zelinskyy G; Buer J; Dittmer U; Kirschning CJ; Lu M
Cell Mol Immunol; 2017 Dec; 14(12):997-1008. PubMed ID: 28757610
[TBL] [Abstract][Full Text] [Related]
78. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling.
Chen F; Du Y; Zhang Z; Chen G; Zhang M; Shu HB; Zhai Z; Chen D
Cell Signal; 2008 Apr; 20(4):666-74. PubMed ID: 18234474
[TBL] [Abstract][Full Text] [Related]
79. Regulation of innate immune signaling by IRAK proteins.
Pereira M; Gazzinelli RT
Front Immunol; 2023; 14():1133354. PubMed ID: 36865541
[TBL] [Abstract][Full Text] [Related]
80. The kinase IRAK4 promotes endosomal TLR and immune complex signaling in B cells and plasmacytoid dendritic cells.
Corzo CA; Varfolomeev E; Setiadi AF; Francis R; Klabunde S; Senger K; Sujatha-Bhaskar S; Drobnick J; Do S; Suto E; Huang Z; Eastham-Anderson J; Katewa A; Pang J; Domeyer M; Dela Cruz C; Paler-Martinez A; Lau VWC; Hadadianpour A; Ramirez-Carrozi V; Sun Y; Bao K; Xu D; Hunley E; Brightbill HD; Warming S; Roose-Girma M; Wong A; Tam L; Emson CL; Crawford JJ; Young WB; Pappu R; McKenzie BS; Asghari V; Vucic D; Hackney JA; Austin CD; Lee WP; Lekkerkerker A; Ghilardi N; Bryan MC; Kiefer JR; Townsend MJ; Zarrin AA
Sci Signal; 2020 Jun; 13(634):. PubMed ID: 32487715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
